Taken together, these findings indicate that reduced IGF1R in breast tumors is associated with alterations in intrinsic tumor epithelial cell pathways as well as extrinsic immune microenvironment signatures that promote metastasis. The gene discussed is IGF1R; the disease is breast neoplasm.